Is Vijaya Diagnostic Centre Ltd (VIJAYA) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Vijaya Diagnostic Centre Ltd is a good quality company .

Is Vijaya Diagnostic Centre Ltd (VIJAYA) undervalued or overvalued?

The key valuation ratios of Vijaya Diagnostic Centre Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is Vijaya Diagnostic Centre Ltd (VIJAYA) share price return in the past 10 years?

Data is not available for this company

Is Vijaya Diagnostic Centre Ltd (VIJAYA) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Vijaya Diagnostic Centre Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

What is the share price of Vijaya Diagnostic Centre Ltd (VIJAYA)?

Company share prices are keep on changing according to the market conditions. The current trading price of Vijaya Diagnostic Centre Ltd (VIJAYA) on 17-Apr-2026 16:59:59 at 16:59 is 1022.25.

What is the market cap of Vijaya Diagnostic Centre Ltd (VIJAYA)?

Market capitalization is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 17-Apr-2026 at 16:59, the market cap of Vijaya Diagnostic Centre stood at Rs. 9884.60 Cr.

What is the P/E ratio of Vijaya Diagnostic Centre?

The latest standalone P/E ratio of Vijaya Diagnostic Centre as of 17-Apr-2026 is 62.40.

What is the P/B ratio of Vijaya Diagnostic Centre Ltd (VIJAYA)?

The latest standalone P/B ratio of Vijaya Diagnostic Centre Ltd (VIJAYA) as of 17-Apr-2026 is 11.12.

What is the 52-week high and low of Vijaya Diagnostic Centre Ltd (VIJAYA)?

The 52-week high of Vijaya Diagnostic Centre Ltd (VIJAYA) is Rs. 1179.55 and the 52-week low is Rs. 847.90.

What is the TTM revenue of Vijaya Diagnostic Centre Ltd (VIJAYA)?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vijaya Diagnostic Centre is Rs. 717.13 (Cr.).

Vijaya Diagnostic Centre Ltd (VIJAYA) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Vijaya Diagnostic Centre Ltd (VIJAYA)
Brand: Vijaya Diagnostic Centre

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	0%	0%	0%	31.6%	35.5%	38%	39.4%	26.5%	30.4%	30.3%	-
Value Creation Index ⓘ	NA	NA	NA	1.3	1.6	1.8	1.8	0.9	1.3	1.2	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	0	293	339	377	462	459	548	681	768
Sales YoY Gr.	-	NA	NA	NA	15.8%	11.2%	22.7%	-0.7%	19.3%	24.4%	-
Adj EPS ⓘ	0	0	0	4.5	6	8.3	10.7	8.3	11.8	14	16.5
YoY Gr.	-	NA	NA	NA	34.2%	37.6%	29.5%	-22.6%	42.7%	18.3%	-
BVPS (₹) ⓘ	0	0	0	20.1	26.9	35.1	45.7	53.2	64.1	77.3	93.9
Adj Net Profit ⓘ	0	0	0	45.6	61.3	84.4	109	84.6	121	144	159
Cash Flow from Ops. ⓘ	0	0	0	90.5	106	130	158	165	183	224	-
Debt/CF from Ops. ⓘ	0	0	0	0.5	0.3	0	0	0	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	15%	13.8%	24.4%
Adj EPS ⓘ	NA	18.4%	9.3%	18.3%
BVPSⓘ	NA	23.5%	19.1%	20.6%
Share Price	-	-	38.7%	-2%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	22	25.4	26.6	26.4	16.7	20.2	19.8	19.3
Op. Profit Mgn % ⓘ	37	39.1	44.1	44.1	39.6	40.3	40.1	40.4
Net Profit Mgn % ⓘ	15.7	18.1	22.6	23.8	18.5	22.3	21.2	20.8
Debt to Equity ⓘ	0.2	0.1	0	0	0	0	0	-
Working Cap Days ⓘ	0	26	30	35	36	28	41	76
Cash Conv. Cycle ⓘ	0	-32	-31	-25	-27	-30	-26	37

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 19.30%

Sales growth is growing at healthy rate in last 3 years 13.80%

Sales growth is good in last 4 quarters at 15.90%

Net Profit has been subdued in last 3 years 9.34%

	Standalone	Consolidated
TTM EPS (₹)	16.4	16.5
TTM Sales (₹ Cr.)	717	768
BVPS (₹) ⓘ	92	93.9
Reserves (₹ Cr.) ⓘ	880	898
P/BV ⓘ	11.12	10.89
PE ⓘ	62.40	62.00

From the Market
52 Week Low / High (₹)	847.90 / 1179.55
All Time Low / High (₹)	292.00 / 1276.75
Market Cap (₹ Cr.)	9,885
Equity (₹ Cr.)	9.7
Face Value (₹)	1
Industry PE ⓘ	86.1

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	293	339	377	462	459	548	681
Operating Expenses ⓘ +	184	206	211	259	277	330	408
Manufacturing Costs	22	25	33	36	44	52	60
Material Costs	40	44	57	71	59	65	85
Employee Cost	54	62	57	71	78	90	112
Other Costs ⓘ	68	75	63	80	96	122	151
Operating Profit ⓘ	108	133	166	204	182	218	273
Operating Profit Margin (%)	37.0%	39.1%	44.1%	44.1%	39.6%	39.7%	40.1%
Other Income ⓘ +	10	15	12	13	14	24	18
Exceptional Items ⓘ	0	0	0	0	0	-2	-1
Interest ⓘ	14	15	15	16	21	24	27
Depreciation ⓘ	40	49	50	53	62	57	71
Profit Before Tax ⓘ	65	83	112	147	114	159	193
Tax ⓘ	19	21	27	37	28	39	49
Profit After Tax	46	63	85	111	85	120	144
PAT Margin (%)	15.8%	18.5%	22.6%	23.9%	18.6%	21.8%	21.1%
Adjusted EPS (₹)	4.5	6.1	8.3	10.8	8.3	11.6	13.9
Dividend Payout Ratio (%)	0%	0%	0%	9%	12%	9%	14%

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	207	275	358	466	543	656	794
Share Capital ⓘ	7	5	5	10	10	10	10
Reserves ⓘ	200	270	354	456	533	646	783
Debt +	33	23	4	1	0	0	0
Long Term Debt	32	22	3	0	0	0	0
Short Term Debt	2	1	1	1	0	0	0
Minority Interest	-0	-0	0	1	2	3	3
Trade Payables	22	22	22	22	28	33	33
Others Liabilities ⓘ	143	161	150	215	273	288	443
Total Liabilities ⓘ	405	481	535	705	845	980	1,274
Fixed Assets
Net Fixed Assets ⓘ +	259	272	268	370	524	742	865
Gross Block	349	392	437	589	800	1,069	1,261
Accumulated Depreciation	89	121	169	219	276	327	396
CWIP ⓘ	3	10	9	34	28	9	70
Investments ⓘ	69	55	28	54	139	109	185
Inventories	2	3	3	4	2	5	5
Trade Receivables	9	8	7	10	9	16	15
Cash Equivalents	53	118	194	192	116	73	49
Others Assets ⓘ	10	16	27	39	27	25	85
Total Assets ⓘ	405	481	535	705	845	980	1,274

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	91	106	130	158	165	183	224
PBT ⓘ	65	83	112	147	114	159	193
Adjustment ⓘ	43	49	53	57	68	60	79
Changes in Working Capital ⓘ	1	-3	-5	-7	9	-1	-7
Tax Paid ⓘ	-19	-23	-31	-40	-26	-34	-40
Cash Flow From Investing Activity ⓘ +	-90	-31	-130	-123	-110	-142	-182
Capex	-59	-37	-31	-121	-125	-85	-93
Net Investments	-31	1	-103	-13	9	82	-93
Others ⓘ	1	6	5	11	6	-140	3
Cash Flow From Financing Activity ⓘ +	-7	-30	-49	-31	-42	-45	-52
Net Proceeds from Shares ⓘ	0	0	0	0	1	3	4
Net Proceeds from Borrowing ⓘ	7	-9	-28	-3	0	0	0
Interest Paid ⓘ	-3	-3	-1	-2	-0	-21	-24
Dividend Paid ⓘ	0	0	0	0	-10	-10	-10
Others ⓘ	-12	-17	-19	-25	-33	-16	-22
Net Cash Flow ⓘ	-6	46	-49	4	13	-4	-9

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	22.58	26.07	26.91	26.85	16.89	19.96	19.84
ROCE (%)	31.56	35.47	37.97	39.37	26.53	30.4	30.27
Asset Turnover Ratio	0.72	0.76	0.74	0.75	0.59	0.6	0.6
PAT to CFO Conversion(x)	1.98	1.68	1.53	1.42	1.94	1.53	1.56
Working Capital Days
Receivable Days	11	9	7	7	8	9	8
Inventory Days	3	3	3	3	3	2	3
Payable Days	196	181	140	112	153	169	142

About Vijaya Diagnostic Centre Ltd

Vijaya Diagnostic Centre is India’s largest B2C-focused integrated diagnostic chain. Headquartered in Hyderabad and established in 1981, the company plays a central role in enabling better health outcomes through quality-led diagnostic services. It brings together radiology and pathology under a single platform, offering patients and clinicians a seamless diagnostic experience across all major testing categories.

The company operates on a hub-and-spoke model that supports both scale and service depth. Its presence spans many cities across Andhra Pradesh, Telangana, West Bengal, Maharashtra, Karnataka and the National Capital Region. The network continues to grow, with increasing reach in large metro markets such as Bengaluru and Pune, alongside continued density in its core Southern base. This integrated approach allows the company to offer a consistent service experience across locations, backed by centralised processing and quality assurance.

The company has consistently invested in advanced diagnostic infrastructure, digital tools and trained professionals to improve accuracy and turnaround times. With a strong emphasis on clinical excellence and patient convenience, the company continues to serve as a trusted diagnostics partner to both individuals and clinicians across India.

Business area of the company

Vijaya Diagnostic Centre is India’s largest B2C-focused integrated diagnostic chain, providing a comprehensive range of radiology and pathology tests with a focus on delivering high-quality services at affordable prices. It in-houses best-in-class equipment, along with specialized and superspecialized radiologists and pathologists to ensure high-quality reporting with quick turnaround times across tests, enabling clinicians in providing efficient and accurate treatment.

Services

Clinical Pathology
Microbiology
Hematology
Serology
Histopathology
Cytogenetics
Biochemistry diagnostic testing
Molecular diagnostics
CT scan
Magnetic Resonance Imaging (MRI)
Ultrasound scan
X-rays
Cardiology
Gastroenterology
Nuclear medicine
Positron Emission Tomography (PET) scan
3 Tesla MRI

Awards, accreditations and recognitions

2012: The company was recognised as one of the Best Imaging Centres in Hyderabad the Week- Hansa Research national survey 2012.
2018: The company was awarded the Healthcare Leadership Award at the Telangana Healthcare Leadership Award 2018.
2018: The Company was awarded the Fastest Growing Brand (Pride of the Nation) 2018-2019 by United Research Services.
2018: The company’s centre at Gurgaon received the ISO 15189:2012 “Medical Laboratories - Requirements for quality and competence” for its facilities in the field of medical testing by NABL.
2019: The company was awarded the Best Diagnostic Centre of the Year, India - 2019 by the Times Healthcare Achievers, The Times of India.
2019: The company was awarded the Best Diagnostic Service Provider of the Year - 2019 at the Six Sigma Healthcare Excellence Awards, 2019.
2019: The company’s centre at Hanamkonda received the ISO 15189:2012 “Medical Laboratories - Requirements for quality and competence” for its facilities in the field of medical testing by NABL.
2019: The company’s centre at Kukatpally received scope of accreditation from NABH.
2020: The Company was awarded the Most Trusted and Best Quality Diagnostic Services in India - 2020 at the COVID Warriors Awards, 2020 by Topgallant Media.
2020: The company’s centre at Himayatnagar received the ISO 15189:2012 “Medical Laboratories - Requirements for quality and competence” for its facilities in the field of medical testing by NABL.
2020: The company’s centre at Sarojini Devi Road received scope of accreditation from NABH.
2020: The company’s centre at Habsiguda received the ISO 15189:2012 by NABL.
2021: The company has received the ‘Award of Excellence’ as the leading Imaging Centre (Multiple City) at the Radiology and Imaging Excellence Awards, 2021.
2021: The company was awarded the Award of Excellence for leading from the front during the pandemic under the Leading Diagnostic Chain of the Year by Elets Technomedia.
2021: The company received the certificate of recognition from the Economic Times as one of the Best Healthcare Brands -2021.
2022: Best Healthcare Brands’ awarded by Economic Times - 2022.
2023: Best Healthcare Brands’ awarded by Economic Times - 2023.
2024: Fastest Growing Leaders 2023- 24 awarded at Asian business & Social Forum 2024, Dubai.
2024: Fastest Growing Brands 2023- 24 awarded at Asian business & Social Forum 2024, Dubai.
2024: Icon in Integrated Diagnostic Services by Times Health Excellence 2024 - Telangana & Andhra Pradesh.
2025: Most Preferred Workplace for Women 2024 - 25 recognized by Marksmen Daily.
2025: Most Trusted Brand of India 2024-25 awarded by Marksmen Daily - 4th edition.
2025: Best Heathcare Brand 2025 - ET Now.

Major events and milestones

1981: Establishment of Vijaya Diagnostic Centre in Hyderabad.
1986: Introduction of Ultrasound & Echocardiography.
1986: Pioneering advanced diagnostic technologies in South India.
1993: Implementation of Fourth Generation CT Scan.
1994: Introduction of Mammography.
1999: Addition of Bone Densitometry.
2000: Introduction of Real Time RT-PCR Assays & Flow Cytometry.
2003: Implementation of Automated Microbiology Culture.
2006: Introduction of Hawkeye Gamma Camera with SPECT.
2007: Addition of Cardiac CT & 3.0 Tesla MRI.
2008: First independent diagnostic centre in South India to offer PET CT.
2009: Introduction of HPV-DNA HC2 test in South India.
2011: First to offer Automated TB identification & Sensitivity in South India.
2012: Introduction of Liquid Based Cytology (Thin Prep) in Andhra Pradesh.
2013: Implementation of Iris iQ200 Automated Urine Analyzer with Microscopy.
2016: First independent centre in Telangana to get Revolution ACT 50 slice CT.
2017: Introduction of Droplet Digital PCR (ddPCR) & Advanced PET CT.
2019: Implementation of USG-ECHO for Cardiology & Advanced CBCT.
2019: Introduction of 3D Mammography with Advanced Technology.
2020: Commencement of COVID testing by RT-PCR in Telangana & AP.
2021: Implementation of Philips DS Achieva with Ambient Experience.
2022: Introduction of ‘Walk-in Walk-out Dual source CT’ and ‘BioMatrix 3T’.
2023: Acquisition of PH Diagnostic Centre Private Limited, marking entry into Western India.
2024: Inauguration of first Vijaya-branded hub in North Kolkata, expanding footprint in Eastern India.
2025: Vijaya took a significant step by launching two centres in Bengaluru, marking its entry into the high-potential Karnataka market.
2025: Received exchange approvals to proceed with the merger of Medinova Diagnostic Services, a move that will further strengthen its back-end capacity and network efficiency.

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Vijaya Diagnostic Centre Ltd (VIJAYA) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Vijaya Diagnostic Share Price